Specialties:
Undergraduate School:
- Harvard University
BA, 1993-1997
Cambridge, MA
Medical School:
- Harvard Medical School
MD, 1997-2003
Boston, MA
Residency:
- Internal Medicine
Stanford University Medical Center
Stanford, CA, 2003-2006
- Internal Medicine Chief Residency
Stanford University Medical Center
Stanford, CA, 2006-2007
Fellowship:
- Stanford University Medical Center
Stanford, CA, 2007-present
|
|
Board Certification:
Clinical/Research Interests:
- Preventive cardiology
- High-density lipoprotein
and reverse cholesterol transport
- Decompensated heart failure
|
Selected Publications:
- deGoma EM, deGoma RL, Rader DJ. Beyond HDL-cholesterol levels:
Evaluating HDL function as influenced by pharmacotherapy. J Am Coll
Cardiol 2008 (in press).
- deGoma EM, Leeper NJ, Heidenreich PA. Clinical significance of
HDL-cholesterol among patients with low LDL-cholesterol. J Am Coll
Cardiol 2008; 51: 49-55.
- Leeper NJ, Ardehali R, deGoma EM, Heidenreich PA. Statin use in
patients with extremely low LDL-cholesterol levels is associated with
improved survival. Circulation 2007;116:613-8.
- Rockson SG, deGoma EM, Fonarow GC. Reinforcing a continuum of care:
In-hospital initiation of long-term secondary prevention following
acute coronary syndromes. Cardiovasc Drugs Ther 2007;21:375-88.
- Rockson SG, deGoma EM. Chapter 17: Peripheral arterial disease. In:
Toth PP, Gotto AM, Jr., editors. Comprehensive Management of High Risk
Cardiovascular Patients. Informa Healthcare, New York 2006.
- deGoma EM, Vagelos RH, Fowler MB, Ashley EA. Emerging therapies for
the management of decompensated heart failure: From bench to bedside.
J Am Coll Cardiol 2006;48:2397-409.
- deGoma EM, Leeper NJ, Heidenreich PA. Clinical significance of HDL-C
levels among patients with LDL-C less than 60 mg/dl. AHA Scientific
Sessions. Chicago, IL. November 15, 2006. Population Science Poster
Competition Winner.
|
